These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8240982)

  • 1. Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3 beta,17 beta-diol in human mammary cancer cells.
    Hackenberg R; Turgetto I; Filmer A; Schulz KD
    J Steroid Biochem Mol Biol; 1993 Nov; 46(5):597-603. PubMed ID: 8240982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
    Chen J; Wang WQ; Lin SX
    J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.
    Hackenberg R; Schulz KD
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):113-7. PubMed ID: 8603031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells.
    Miyamoto H; Yeh S; Lardy H; Messing E; Chang C
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11083-8. PubMed ID: 9736693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells.
    Adams J; Garcia M; Rochefort H
    Cancer Res; 1981 Nov; 41(11 Pt 1):4720-6. PubMed ID: 6458355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
    Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y
    Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.
    Poulin R; Labrie F
    Cancer Res; 1986 Oct; 46(10):4933-7. PubMed ID: 2944574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells.
    Chang HC; Miyamoto H; Marwah P; Lardy H; Yeh S; Huang KE; Chang C
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11173-7. PubMed ID: 10500149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.
    Boccuzzi G; Brignardello E; Di Monaco M; Gatto V; Leonardi L; Pizzini A; Gallo M
    Br J Cancer; 1994 Dec; 70(6):1035-9. PubMed ID: 7981051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone and androst-5-ene-3 beta,17 beta-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor.
    Adams JB; Archibald L; Seymour-Munn K
    Cancer Res; 1980 Oct; 40(10):3815-20. PubMed ID: 6449285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
    Poortman J; Prenen JA; Schwarz F; Thijssen JH
    J Clin Endocrinol Metab; 1975 Mar; 40(3):373-9. PubMed ID: 163841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal C19-5-ene steroids induce full estrogenic responses in rat pituitary gonadotrophs.
    Simard J; Labrie F
    J Steroid Biochem; 1987 May; 26(5):539-46. PubMed ID: 2953941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions and interactions of delta 5-androstene-3 beta, 17 beta-diol and 17 beta-estradiol in the immature rat uterus.
    van Doorn LG; Poortman J; Thijssen JH; Schwarz F
    Endocrinology; 1981 Apr; 108(4):1587-93. PubMed ID: 7472285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
    Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
    Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
    Guerini V; Sau D; Scaccianoce E; Rusmini P; Ciana P; Maggi A; Martini PG; Katzenellenbogen BS; Martini L; Motta M; Poletti A
    Cancer Res; 2005 Jun; 65(12):5445-53. PubMed ID: 15958594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cells.
    Hackenberg R; Hannig K; Beck S; Schmidt-Rhode P; Scholz A; Schulz KD
    Eur J Cancer; 1996 Apr; 32A(4):696-701. PubMed ID: 8695275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
    Poulin R; Baker D; Labrie F
    Breast Cancer Res Treat; 1988 Oct; 12(2):213-25. PubMed ID: 3242650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
    He D; Falany CN
    Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and effects of 5 alpha-androstane-3 beta,17 beta-diol in the male rat pituitary.
    Thieulant ML; Benie T; Michaud S; Klein H; Vessieres A
    J Steroid Biochem; 1983 Jul; 19(1A):241-6. PubMed ID: 6887860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth.
    Hackenberg R; Hofmann J; Wolff G; Hölzel F; Schulz KD
    J Cancer Res Clin Oncol; 1990; 116(5):492-8. PubMed ID: 2229140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.